A rise in antibacterial drug resistance comes at a time when our once reliable sources of antibacterial natural products, bacteria and fungi, are failing us. The search for new drugs to fight pathogens has led to a range of innovative approaches and includes screening organisms which have developed evolutionary adaptions to prevent bacterial attack. The discovery of antibacterial phytochemicals from plants can be achieved using an activity-guided platform involving biological and chemical pre-screening, compound isolation, structure elucidation, and the direct testing of isolated compounds. Challenges include the clean isolation of natural products, avoiding the rediscovery of known compounds, toxicity, and poor levels of activity. For a good part of the 20th century, humans had the upper hand against bacterial pathogens thanks to the pioneering work of Alexander Fleming, René Dubos and Selman Waksman et al. who demonstrated the value of mining antibacterial natural products from bacteria and fungi. For a few decades this approach (which yielded the likes of penicillin, streptomycin and tetracycline) seemed to be an impenetrable fortress against bacterial pathogens, until the walls began to strain under the force of growing antimicrobial resistance and a dearth of new antibiotic classes 1 . The 'old' approach eventually failed to produce significantly new clinical agents against the background of known compounds 1 . Researchers have responded in a range of novel ways: running large compound libraries through high throughput screenings 2 , mining the natural products in previously unculturable organisms 3 , screening the chemicals hidden away on the shelves of chemistry labs 4 , disarming bacteria of their virulence factors 5 , and developing phage therapies 6 ; each approach with its merits and limitations. Another approach is screening botanical natural products. The plant world as a whole is estimated to produce over 100 000 secondary metabolites with low molecular mass, generally derived from isoprenoid, phenylpropanoid, alkaloid and fatty acid or polyketide pathways 7 . While plants and animals have some common antibacterial defences such as apoptosis of infected tissue, antibacterial peptides (purothionins from Triticum aestivum 8 are a noteworthy plant-based example) and the targeted exploitation of reactive oxygen species, they do not produce antibodies, relying instead on a limited number of receptors to recognize pathogens along with a diverse armoury of small molecules with antibacterial activity 9 . Compounds with known specific antibacterial targets are not common in plants, although there are examples such as coumarins with comparable action to the DNA-gyrase inhibitor novobiocin 9 . While activity is usually weak, it is possible that plants target virulence rather than growth or that relatively weak antibacterial agents work in synergy with each other to create potent activity as seen with the antibacterial compound berberine from Berberis fremontii together with the multi drug resistance (MDR) pump inhibitor 5'-methoxyhydnocarpin 9,10 . Important phytochemical groups include phenolics and polyphenols, quinones, coumarins, flavonoids, terpenoids and alkaloids 11 (Figure 1). Phenolics and polyphenols include the simple phenols, phenolic acids and tannins. Antibacterial examples are found in the tea plant Camellia sinensis and include gallic acid, a phenolic acid which disrupts cell membranes 12,13 , and the tannin tannic acid which reduces Staphylococcus aureus biofilm formation 14 . A representative of the quinones is juglone found in the black walnut tree Juglans nigra 15 , while the coumarins include osthole found in Arracacia tolucensis var. multifida 16 . Flavonoids include myricetin, found in the sweet potato plant Ipomoea batatas and which appears to affect protein synthesis 17,18 .
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In Focus
Terpenoids are common phytochemicals based on the isoprene structure and include terpinen-4-ol, an antibacterial terpene found abundantly in Melaleuca alternifolia tea tree oil 19 , which evidence suggests leads to damage to the cell membrane and loss of cytoplasmic material 20 There are many ways to decipher a plant's defences to find these antibacterial small molecules and these are accessible to a microbiologist who has support from a multidisciplinary team that includes a chemist and botanist. A simple schema developed in our lab is shown in Figure 2 and involves plant collection, secondary 
Post isolation
Characterisation of new compounds generally requires specialist knowledge and tools from a chemist and includes the use of NMR and/or crystallography. Further studies on highly active novel compounds may include mechanism of action and cytotoxicity assays.
Antibacterial pre-screening
Extract is applied to blank disks for a disk diffusion assay on a range of target organisms.
Dereplication

GCMS analysis assists in
identifying if an extract is rich in known volatile antimicrobial compounds by matching spectra and retention times against databases.
TLC bioautography
Extract is separated into components using a thin layer chromatography (TLC) plate and overlayed with bacteriaseeded media to identify active components.
Isolation
Flash chromatography is a relatively simple and accessible method for compound isolation, although prep-HPLC provides better separation. To ensure the correct fractions are further purified and characterised, they are re-tested using TLC bioautography.
Minimum inhibition concentrations
Run on isolated compounds, MICs can be undertaken by adapting the CLSI methods. Generally, starting concentrations need to be relatively low and DMSO is often included to improve solubility during assays.
Collection & extraction
Plants are collected and secondary metabolites extracted by soaking dried (or fresh) plant material in a solvent (e.g., methanol) for around 24 h. The extract is filtered and solvent evaporated. In Focus
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